Latest news with #MikeCurtis
Yahoo
14 hours ago
- Sport
- Yahoo
Mavericks' makes interesting Cooper Flagg decision
Mavericks' makes interesting Cooper Flagg decision originally appeared on The Sporting News It seems that the Dallas Mavericks are switching things up for Cooper Flagg this coming 2025-26 NBA season. Throughout Flagg's basketball career, he had always played in the forward position. He mainly played at the small forward position. However, it appears that the Mavericks are going to experiment with some new lineups, with Flagg playing at the guard position. According to Mavericks beat writer Mike Curtis, Dallas has officially added Flagg to their website as part of the main roster. What caught Curtis' attention was the fact that he was listed at the guard position. While his secondary position does say he'll play as a forward, it was intriguing to learn about the team's intention to let him play at the backcourt. Kyrie Irving's absence could be why Cooper Flagg will play guard While everyone is looking forward to the Dallas Mavericks' starting five of Kyrie Irving, Klay Thompson, Cooper Flagg, Anthony Davis, and Dereck Lively II, it might take some time until we see them at full force. Last season, Irving tore his ACL, which sidelined him for the rest of the season. Based on the current timeline provided by sources, Irving is expected to make his return by January 2026. Having that in mind, we could theorize that Flagg's enlistment at the guard position could be due to Irving's absence. As of the time of this writing, the Mavericks have yet to reveal their intentions of having Flagg play in the backcourt. Whatever the case may be, we'll just have to wait and see if Mavericks head coach Jason Kidd can efficiently utilize the rookie in the backcourt. Dallas is set to face off against the Oklahoma City Thunder on October 6 in the 2025 NBA Preseason opener.
NBC News
15-04-2025
- Health
- NBC News
FDA OKs trial of pig livers as dialysis-like treatment for liver failure
U.S. researchers will soon test whether livers from a gene-edited pig could treat people with sudden liver failure — by temporarily filtering their blood so their own organ can rest and maybe heal. The first-of-its-kind clinical trial has been cleared by the Food and Drug Administration, according to pig producer eGenesis, which announced the step Tuesday with its partner OrganOx. An estimated 35,000 people in the U.S. are hospitalized each year when their liver suddenly fails. There are few treatment options and death rates as high as 50%. Many don't qualify for a liver transplant or can't get a match in time. The new study, which is expected to get underway later this spring, is a twist on the quest for animal-to-human organ transplants. Researchers won't transplant the pig liver but instead will attach it externally to study participants. The liver is the only organ that can regenerate, but the question is whether having the pig's liver filter the patient's blood for several days could give it that chance. In experiments with four deceased bodies, that 'bridge' attempt showed the pig liver could support some functions of a human liver for two or three days, said Mike Curtis, CEO of Massachusetts-based eGenesis, which genetically modifies pigs so their organs are more humanlike. The trial will enroll up to 20 patients in intensive-care units who don't qualify a liver transplant, he said. A device made by Britain's OrganOx, currently used to preserve donated human livers, will pump participants' blood through the pig liver. It's the latest step in attempts to use gene-edited pig organs to save human lives. Pig kidneys from eGenesis and another pig producer, United Therapeutics, are being used in experimental transplants.
Boston Globe
15-04-2025
- Health
- Boston Globe
FDA OKs trial of pig livers as dialysis-like treatment for liver failure
The new study, which is expected to get underway later this spring, is a twist on the quest for animal-to-human organ transplants. Researchers won't transplant the pig liver but instead will attach it externally to study participants. Advertisement The liver is the only organ that can regenerate, but the question is whether having the pig's liver filter the patient's blood for several days could give it that chance. Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up In experiments with four deceased bodies, that 'bridge' attempt showed the pig liver could support some functions of a human liver for two or three days, said Mike Curtis, CEO of Massachusetts-based eGenesis, which genetically modifies pigs so their organs are more humanlike. The trial will enroll up to 20 patients in intensive-care units who don't qualify a liver transplant, he said. A device made by Britain's OrganOx, currently used to preserve donated human livers, will pump participants' blood through the pig liver. It's the latest step in attempts to use gene-edited pig organs to save human lives. Pig kidneys from eGenesis and another pig producer, United Therapeutics, are being used in experimental transplants. Advertisement The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Associated Press
15-04-2025
- Health
- Associated Press
FDA OKs trial of pig livers as dialysis-like treatment for liver failure
WASHINGTON (AP) — U.S. researchers will soon test whether livers from a gene-edited pig could treat people with sudden liver failure — by temporarily filtering their blood so their own organ can rest and maybe heal. The first-of-its-kind clinical trial has been cleared by the Food and Drug Administration, according to pig producer eGenesis, which announced the step Tuesday with its partner OrganOx. An estimated 35,000 people in the U.S. are hospitalized each year when their liver suddenly fails. There are few treatment options and death rates as high as 50%. Many don't qualify for a liver transplant or can't get a match in time. The new study, which is expected to get underway later this spring, is a twist on the quest for animal-to-human organ transplants. Researchers won't transplant the pig liver but instead will attach it externally to study participants. The liver is the only organ that can regenerate, but the question is whether having the pig's liver filter the patient's blood for several days could give it that chance. In experiments with four deceased bodies, that 'bridge' attempt showed the pig liver could support some functions of a human liver for two or three days, said Mike Curtis, CEO of Massachusetts-based eGenesis, which genetically modifies pigs so their organs are more humanlike. The trial will enroll up to 20 patients in intensive-care units who don't qualify a liver transplant, he said. A device made by Britain's OrganOx, currently used to preserve donated human livers, will pump participants' blood through the pig liver. It's the latest step in attempts to use gene-edited pig organs to save human lives. Pig kidneys from eGenesis and another pig producer, United Therapeutics, are being used in experimental transplants. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
The Independent
15-04-2025
- Health
- The Independent
FDA OKs trial of pig livers as dialysis-like treatment for liver failure
U.S. researchers will soon test whether livers from a gene-edited pig could treat people with sudden liver failure — by temporarily filtering their blood so their own organ can rest and maybe heal. The first-of-its-kind clinical trial has been cleared by the Food and Drug Administration, according to pig producer eGenesis, which announced the step Tuesday with its partner OrganOx. An estimated 35,000 people in the U.S. are hospitalized each year when their liver suddenly fails. There are few treatment options and death rates as high as 50%. Many don't qualify for a liver transplant or can't get a match in time. The new study, which is expected to get underway later this spring, is a twist on the quest for animal-to-human organ transplants. Researchers won't transplant the pig liver but instead will attach it externally to study participants. The liver is the only organ that can regenerate, but the question is whether having the pig's liver filter the patient's blood for several days could give it that chance. In experiments with four deceased bodies, that 'bridge' attempt showed the pig liver could support some functions of a human liver for two or three days, said Mike Curtis, CEO of Massachusetts-based eGenesis, which genetically modifies pigs so their organs are more humanlike. The trial will enroll up to 20 patients in intensive-care units who don't qualify a liver transplant, he said. A device made by Britain's OrganOx, currently used to preserve donated human livers, will pump participants' blood through the pig liver. It's the latest step in attempts to use gene-edited pig organs to save human lives. Pig kidneys from eGenesis and another pig producer, United Therapeutics, are being used in experimental transplants. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
